Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details Textual)

v3.8.0.1
Commitments and Contingencies (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Jan. 14, 2017
Dec. 31, 2015
Sep. 30, 2017
Sep. 30, 2016
Jun. 30, 2015
Dec. 30, 2013
Apr. 30, 2013
Commitments and Contingencies [Line Items]              
Research and Development Expense, Total     $ 985,000 $ 820,000      
Royalty Guarantees, Commitments, Amount     $ 200,000        
Long Term Purchase Commitment Expire Date     Dec. 31, 2015        
Commitments [Member]              
Commitments and Contingencies [Line Items]              
Research Services Agreements Value Fulfilling Commitment   $ 3,000,000          
License Costs $ 30,627            
Initial license fee 20,000            
Contractual Obligation, Due in Next Twelve Months           $ 78,000  
Contractual Obligation, Due in Second Year           $ 161,754  
Settlement Agreement [Member]              
Commitments and Contingencies [Line Items]              
Prepaid Expense             $ 1,000,000
Amended Agreement [Member]              
Commitments and Contingencies [Line Items]              
Research and Development Expense, Total         $ 2,100,000    
Minimum [Member] | Commitments [Member]              
Commitments and Contingencies [Line Items]              
License Costs 25,000            
Maximum [Member] | Commitments [Member]              
Commitments and Contingencies [Line Items]              
License Costs $ 150,000            
Fraunhofer [Member]              
Commitments and Contingencies [Line Items]              
Royalty Guarantees, Commitments, Amount     $ 4,000,000        
Other Commitments, Description     under the terms of the TTA and for a period of 15 years, the Company shall pay Fraunhofer one percent (1%) of all receipts derived by the Company from sales of products produced utilizing the iBioLaunch or iBioModulator technology and ten percent (10%) of all receipts derived by the Company from licensing either of those technologies to third parties.